Hamner, UNC launch Institute for Drug Safety Sciences - Triangle Business Journal:

grihanovveimavox.blogspot.com
Liver toxicity is a main reason for regulatory agencies to deny approvao for new drugs or take action againsexisting drugs. The researchers, who are working at the newlyg formed Institute for DrugSafety Sciences, will use a virtuak model of a liver to test how different drugws may affect the organ. The research has the potentiaol to speed up the drug development and testing The Institute for DrugSafety Sciences, whicjh opened last week and features a 14,000-square-fooy research laboratory, will work to studyy global drug safety issues. It is being led by Paul the Verne S. Caviness distinguished professor of medicineat UNC.
along with his scientist colleagues, will work with membersz of the biomedical andpharmaceuticao sector, the U.S. Food and Drug Administration and the Nationall Institutes of Health to develop new drug safety initiatives. The Institute for Drug Safety Sciences was born from an agreementg signed in April 2008 between UNC and Hamned to collaborate on research intodrug safety, drug development and publi health. It is located on Hamner’s campus in Research Triangle Park.